Abstract:Background: IBS and IBD are chronic gastrointestinal (GI) conditions associated with abdominal pain and abnormal bowel habits.Although IBS and IBD share common symptoms, their pathogenesis differs.Whereas IBD symptoms often arise from inflammatory or structural abnormalities, these objective markers are not consistently identified in IBS.Because symptom pathogenesis differs between disorders, we aimed to test whether symptom severity also varies between IBS and IBD.Methods: We compared GI symptoms using items developed for the NIH Patient Reported Outcome Measurement Information System (PROMIS®) that assessed frequency, severity, interference, and bother to 3 groups: (1) IBS patients from clinic and community populations, (2) IBD clinic patients, and (3) a U.S. general population (GP) sample selected by a commercial research firm (Cint) to approximate characteristics in the 2010 census.We measured 8 GI symptom domains: gastroesophageal reflux (GERD), disrupted swallowing, nausea/vomiting (N/V), belly pain, diarrhea, constipation, gas/bloating, and fecal incontinence/soling (FI).We measured overall symptom severity by averaging responses to items and transforming linearly to a 0-100 possible range (higher=worse).We compared group differences using analysis of covariance controlling for demographics and GI symptom-specific anxiety (Visceral Sensitivity Index [VSI]).To adjust for multiple comparisons for different symptoms, a p ,0.01 was used.Results: Respondents included 231 with IBS (mean age=44.8yrs; 68%F; 56.3% Caucasian), 190 with IBD (mean age=41.3yrs; 46%F; 58.4% Caucasian) and 1117 from the GP (mean age 45.7; 57%F; 72.7% Caucasian).Mean age, race/ethnicity, and education significantly differed between groups (all p ,0.01).The Table shows differences in GI symptom severity scores between groups.The GP had greater severity of GERD, disrupted swallowing and N/V compared to the patient groups.GERD severity differed among all groups with greatest severity in GP, followed by IBS, and then IBD.GP reported more disrupted swallowing than IBS and greater N/V than IBD.IBS patients reported greater severity of belly pain vs. GP and greater severity of constipation and gas/ bloating vs. GP and IBD.IBD patients had more severe diarrhea than the GP but not IBS.Conclusions: While IBS and IBD are conditions associated with greater lower GI symptom severity compared to the GP, they report less severe upper GI symptoms.Between disease states, IBS patients report numerically worse symptom severity vs. IBD for 7 of 8 GI symptom domains -only diarrhea appeared more severe in IBD.Although IBD is marked by objective inflammatory and anatomic biomarkers, this does not necessarily yield worse symptom severity than IBS -a condition without reliable biomarkers; the converse is true in this study.* P values after controlling for demographics and VSI.Values shown in bold are statistically significant.

The change of visceral sensitivity to intra-rectal different temperature stimulation in patients with irritable bowel syndrome

Lactose Intolerance In Irritable Bowel Syndrome Patients With Diarrhoea: The Roles Of Anxiety, Activation Of The Innate Mucosal Immune System And Visceral Sensitivity

Study of Visceral Hypersensitivity in Irritable Bowel Syndrome.

Central and peripheral hypersensitivity in the irritable bowel syndrome

Tu2066 Prevalence of Irritable Bowel Syndrome in China: Joint Effects of Psychiatric Morbidity with Life Event Stress and Lactose Intake

OC-035 Mechanism of Lactose Intolerance in Irritable Bowel Syndrome: Role of Anxiety, Mucosal Immunity and Visceral Hypersensitivity

Mechanism of Hypersensitivity in the Patients with Irritable Bowel Syndrome

Study on clinical significance of different subgroups of irritable bowel syndrome patients in Zhejiang province

Alterations in Focal Encephalic Function in Patients of Irritable Bowel Syndrome

Study on Changes of Colorectal Serotonin Transporter in Rats with Visceral Hypersensitivity and Treatment with Traditional Chinese Medicine Changji'an

A Clinical Study on Colonic Motility and Anorectal Manometry in Irritable Bowel Syndrome with Constipation and Functional Constipation

Changes of Colonic 5-Hydroxytryptamine and 5-Hydroxytryptamine3 Receptor in Diarrhea-predominant Irritable Bowel Syndrome

The differences of rectal perception among dirrhea-dominant, constipationdominant irritable bowel syndrome and functional constipation

Changes of Substance P, Vasoactive Intestinal Peptide and Mast Cell in Colonic Mucosa of Patients with Irritable Bowel Syndrome

Changes of colonic 5-hydoxytryptamine and 5-hydroxytryptamine, receptor in diarrhea-predominant irritable bowel syndrome

The changes of brain pain functional areas in patients with overlap syndrome of functional dyspepsia and irritable bowel syndrome

Rectal Hypersensitivity Reduced by Acupoint TENS in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

The Brain-Gut Axis Mechanism of Visceral Hypersensitivity of Rats with Irritable Bowel Syndrome

Effect of Changji'an on Visceral Hypersensitivity in Rats with Irritable Bowel Syndrome and Its Mechanism

[The Changes of Mucosal Mast Cells and Substance P in Patients with Irritable Bowel Syndrome].

Study of Colonic 5-HT3 Receptors in Diarrhea Prominent Irritable Bowel Syndrome